Article info
Editorial
Mesenchymal stromal cells and the acute respiratory distress syndrome (ARDS): challenges for clinical application
- Correspondence to Dr D F McAuley, Centre for Infection and Immunity, Queen's University Belfast, Health Sciences Building, 97 Lisburn Road, Belfast BT9 7BL, UK; d.f.mcauley{at}qub.ac.uk
Citation
Mesenchymal stromal cells and the acute respiratory distress syndrome (ARDS): challenges for clinical application
Publication history
- First published May 19, 2015.
Online issue publication
September 01, 2022
Article Versions
- Previous version (29 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions